| http://www.w3.org/ns/prov#value | - Natalizumab (Tysabri)Natalizumab (Tysabri) is a monoclonal antibody drug approved for treatment of MS. Monoclonal antibodies (MAbs) are immune proteins that have specific targets, including viruses, proteins, different cells and even other antibodies.
|
